Abstract:Purpose: Runt-related transcription factor 2 (RUNX2) also known as core-binding factor subunit alpha-1 belongs to the family of runt domain transcription factors. RUNX2 is essential for the maturation of osteoblasts and both intramembranous and endochondral ossification. In the articular cartilage, RUNX2 regulates MMP13 expression and is involved in the pathophysiology of osteoarthritis (OA). However, transcriptional regulation mechanism of RUNX2 in articular chondrocytes is far from clear. RUNX2 has two major isoforms. Type II isoform is restricted to osseous cells and mature chondrocytes, and the transcription is initiated at the distal promoter P1. Importantly the RUNX2 P1 promoter has a fragment containing a 600bp of sequence upstream of the transcription start sufficient for promoter activity, with only a few CpG sites contained in this region. We hypothesized that methylation status at specific CpG sites in the RUNX2 P1 promoter predominantly regulate promoter activity and correlate with messenger RNA levels in human chondrocytes. Methods: The superficial and deep zone of cartilage from patients with a fracture of the neck of femur (NOF; n = 11) were used for isolation of non-OA/healthy chondrocytes, whereas cartilage pieces adjacent to weight-bearing areas of OA femoral heads (lacking surface zones) were harvested to obtain OA chondrocytes (n = 15). Gene expression levels and percentage methylation of CpG sites within the RUNX2 P1 promoter were quantified by qRT-PCR and bisulfite pyrosequencing. Isolated primary human chondrocyte samples (n = 6) were cultured for 5 weeks in 3 groups: (i) cultured without treatment (control culture) and (ii) cultured using 2 μM 5-azadeoxycytidine (5-aza-dC). The effect of CpG methylation on RUNX2 promoter activity was determined using a CpG-free vector. Furthermore, to determine the CpG sites critical for RUNX2 promoter activity, RUNX2 wild type promoter construct activity was compared against 4 vectors containing mutations at different CpG sites. Results: RUNX2 expression in OA and NOF deep chondrocytes were 34-fold (p < 0.01) and 79-fold (p < 0.01) higher compared to NOF superficial chondrocytes. OA chondrocytes displayed a 10%, 14%, 32% and 41% statistically significant (P<0.01) reduction in methylation status at the −720, −686, −336 and +17 CpG sites respectively, whereas NOF deep chondrocytes a 13% and 19% reduction at the -336 and +17 CpG sites. A significant negative correlation was observed between RUNX2 gene expression and the percentage methylation of the CpG sites in OA chondrocytes. MMP13 expression in OA chondrocytes was 27-fold and 89-fold higher than observed n NOF superficial and deep chondrocytes, respectively. A significant positive correlation was observed between RUNX2 and MMP13 gene expressions in OA chondrocytes. RUNX2 expression by chondrocytes cultured using 5-aza-dC was observed to be 3.3-fold higher than in control culture chondrocytes. Significantly, the percentage methylation of the CpG site located at −336-bp in 5-aza-dC culture was lower than observed in control culture (55% vs. 87%). In vitro DNA methylation was noted to decrease RUNX2 promoter activity. Point mutations (CG to TG) created at the −336 and +17 CpG sites resulted in a significant reduction in RUNX2 P1 promoter activity. Conclusions: The current studies show that the increased expression of MMP13 in human osteoarthritic chondrocytes is correlated with RUNX2 expression. Critically, we show, methylation status of specific CpG sites in the P1 promoter is a key regulator of RUNX2 expression in human chondrocytes. These studies show for the first time that the percentage methylation of specific CpG sites correlates with RUNX2 gene expression level in clinical OA samples. Furthermore, point mutations created at the −336 and +17 CpG sites resulted in a significant reduction in RUNX2 P1 promoter activity. These findings indicate that CpG sites located at −336 and +17 are crucial regulators of RUNX2 transcription and offer a putative target for pharmacological intervention in the treatment of OA.

Association of Reduced Type IX Collagen Gene Expression in Human Osteoarthritic Chondrocytes with Epigenetic Silencing by DNA Hypermethylation.

Epigenetic regulation of interleukin-8, an inflammatory chemokine, in osteoarthritis

Activation of the P38/CREB/MMP 13 Axis is Associated with Osteoarthritis

Searching Potential Transcription Factors Regulating Mmp13 Overexpression Via Promoter Cpg Methylation Status in Human Osteoarthritic Chondrocytes: A Microarray Screening

Runx2 Expression is Regulated by Methylation Status of Specific Cpg Sites in the P1 Promoter and Correlates with Mmp13 Expression in Human Osteoarthritic Chondrocytes

Correlation Analysis of SOX9, -5, and -6 as well as COL2A1 and Aggrecan Gene Expression of Collagen I Implant–Derived and Osteoarthritic Chondrocytes

OC01: INFLAMMATORY CYTOKINES CAUSE LOSS OF DNA METHYLATION TOGETHER WITH INDUCTION OF ABNORMAL GENE EXPRESSION IN HEALTHY HUMAN ARTICULAR CHONDROCYTES

Use of Integrative Epigenetic and Mrna Expression Analyses to Identify Significantly Changed Genes and Functional Pathways in Osteoarthritic Cartilage.

Suppressors of cytokine signalling (SOCS) are reduced in osteoarthritis

The Epigenetic Effect of Glucosamine and A Nuclear Factor-Kappa B (Nf-Kb) Inhibitor on Primary Human Chondrocytes - Implications for Osteoarthritis

DNA methylation of the RUNX2 P1 promoter mediates MMP13 transcription in chondrocytes

Set7/9 Impacts COL2A1 Expression Through Binding and Repression of SirT1 Histone Deacetylation

Dissecting SOX9 dynamics reveals its differential regulation in osteoarthritis

Effects of 5-aza-2´-deoxycytidine on primary human chondrocytes from osteoarthritic patients

DNA Methylation Profiling in Chondrocyte Dedifferentiation in Vitro

Decreased histone H3K9 dimethylation in synergy with DNA demethylation of Spi‐1 binding site contributes to ADAMTS‐5 expression in articular cartilage of osteoarthritis mice

REST Corepressor (corest) Repression Induces Phenotypic Gene Regulation in Advanced Osteoarthritic Chondrocytes

Subchondral bone osteoblasts induce phenotypic changes in human osteoarthritic chondrocytes

Identification of Abnormally Methylated–differentially Expressed Genes and Pathways in Osteoarthritis: a Comprehensive Bioinformatic Study

STAT3 promotes a youthful epigenetic state in articular chondrocytes

Integrative epigenomics, transcriptomics and proteomics of patient chondrocytes reveal genes and pathways involved in osteoarthritis